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ABSTRACT
Aim: The aim of this study was to assess the incidence and
susceptibility to antibacterial agents of anaerobic strains in 118
patients with head and neck abscesses (31) and cellulitis (87).
Materials and methods: In total, 118 pus specimens from 118
consecutive patients with abscesses (31 cases) and cellulitis
(87) of the head and neck were evaluated from 2006 to the end of
2011. The patients were admitted to the University Hospital of
Maxillofacial Surgery, Bhopal, India, and comprised 76 men and
42 women: Four children, 103 adults and 11 elderly people.
Results: Anaerobic bacteria (174 strains within 18 genera) were
found in 88 (74.6%) of the 118 specimens. Anaerobes only were
present in 23 (19.5%) specimens, aerobic/facultative bacteria only
in 20 (16.9%) and mixed aerobic/anaerobic flora in 65 (55.1%).
No growth was detected in 10 (8.5%) specimens. Two or more
anaerobes per specimen were found in 56 (63.6%) of the
specimens yielding anaerobes. The incidence of isolation of
anaerobes from patients with identified odontogenic sources of
infection was 82.2% (60 of 73 cases) and that in patients with
other sources of infection was 71.4% (15 of 21, p > 0.20).
Conclusion: The start of empirical treatment could influence the
frequency or rate of isolation of Fusobacterium species. The
involvement of the Bacteroides fragilis group in some head and
neck infections should be considered.
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INTRODUCTION
Anaerobic bacteria are important pathogens in head and neck
infections.1 According to several authors resistance rates to
some antibacterial agents (such as ampicillin/sulbactam and
clindamycin) have shown a tendency to increase.2,3 The
treatment of infections in maxillofacial surgery involves
surgical procedures and application of antibacterial agents.4
Most head and neck infections are endogenous and mixed
in nature.5 Thus, the antibacterial treatment of mixed infections
should cover both aerobes and anaerobes. Resistance rates
for anaerobes vary within species as well as within sources of
the isolates. Anaerobic bacterias are a common cause of
infections, some of which can be serious and life-threatening.
Because anaerobes are the predominant components of the
skin’s and mucous membranes normal flora, they are a
common cause infections of endogenous origin. Because of
their fastidious nature, anaerobes are hard to isolate and are
often not recovered from infected sites. The administration
of delayed or inappropriate therapy against these organisms
may lead to failures in eradication of these infections. The
isolation of anaerobic bacteria requires adequate methods for
collection, transportation and cultivation of clinical
specimens. The management of anaerobic infection is often
difficult because of the slow growth of anaerobic organisms,
which can delay their identification by the frequent
polymicrobial nature of these infections and by the increasing
antimicrobial resistance of anaerobic bacteria to antimicrobials.
The aim of this study was to know the incidence and
susceptibility patterns to antibacterial agents of anaerobes in
patients with abscesses and cellulitis of the head and neck over
a period of 5 years and to assess the influence of the start of
empirical treatment on the isolation rates of the anaerobes.
MATERIALS AND METHODS
Patients
In total, 118 pus specimens were randomly selected from 118
patients with abscesses (31 cases) and cellulitis (87) of the
head and neck which were evaluated from 2006 to the end of
2011. The patients were admitted to the People’s University
Hospital of Maxillofacial Surgery, Bhopal, India and
comprised 76 men and 42 women: Four children, 103 adults
and 11 elderly people.
The sites of infection were submandibular or
parapharyngeal (80 cases, 50 of them affecting the floor of
the mouth), neck (6) and facial (32). The site of origin of the
infections was identified in 94 patients (79.7% of all patients).
The mean age of the patient was 42 years. Pregnant women
and patient with blood dyscrasias were excluded from the study.
Informed consent was taken. The most common source was
odontogenic infection, occurring in 73 cases (77.7%). Other
sources involved salivary gland infections (7 cases), trauma
(6), upper airway (5) and other infections (3). Three patients
suffered from diabetes and three patients had malignant
diseases. Most (73.7%, 87 of 118) patients were evaluated
after the start of empirical treatment in the hospital with
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-lactams (24 cases), metronidazole (5), both agents (52) and
other antibacterial drugs (6) for 1 to 3 days.
Strain isolation and culture: After skin disinfection with
70% ethanol and iodophor, pus aspirates were taken by needle
aspiration or during incision. The specimens were placed in
Stuart transport medium (Merck) and processed within 2 hours
of collection. The specimens were inoculated onto Brucella
agar (Becton Dickinson) enriched with hemin, vitamin K
(Becton Dickinson) and 5% sheep blood. Part of each
specimen was placed in Komkova anaerobic broth [National
Centre of Infectious and Parasitic Diseases (NCIPD)], which
was boiled for 5 to 10 minutes used and cooled prior to use.
Komkova broth is a cooked-meat medium, containing glucose,
gelatin and 0.3% agar.6 After inoculation, the Komkova
anaerobic broth was overlaid with 1 to 2 ml sterile liquid
paraffin and incubated at 37°C. The broth was subcultured after
48 to 72 hours on enriched Brucella blood agar. A direct smear
was made and examined after Gram staining with 0.1% basic
fuchsin as a counterstain. The specimens were plated on blood
agar plates as an aerobic control. Anaerobic media were
incubated using GasPak anaerobic system envelopes (Becton
Dickinson) or Anaerobe Pack (NCIPD) at 37°C for up to 7 or
14 days, when actinomycosis was clinically suspected.
Anaerobic strains were identified by Gram stain, colonial
morphology, aerobic control, susceptibility to special potency
disks, catalase, spot indole and API system Rapid ID 32 A.2
Antibacterial Susceptibility Testing
The special potency disks (Rosco and Becton Dickinson)
contained oxgall, kanamycin (1,000 µg), colistin (10 µg) and
metronidazole (5 µg).
The antibacterial susceptibility of 151 anaerobic strains was
evaluated by using an agar dilution method with two to three
consecutive concentrations.7 Enriched Brucella blood agar
plates containing the following agents were used (µg  ml–1):
Amoxicillin (0.5, 1 and 2), clindamycin (2 and 4), ampicillin/
sulbactam (8/4 and 16/8) and metronidazole (8, 16 and 32).
The bacteria inoculum corresponded to 0.5 McFarland
standard and the final inoculum was about 105 CFU per spot.7
When no growth was observed on the plate after 48 hours of
anaerobic incubation, the isolate was considered to be
susceptible to the agent. Breakpoints for intermediate
susceptibility and resistance to amoxicillin (for Gram-negative
anaerobes), clindamycin, ampicillin/sulbactam and
metronidazole were 1 and 2, 4 and 8, 16/8 and 32/16 and 16
and 32 µg ml–1, respectively.7
According to in vitro data, the minimum inhibitory
concentrations (MICs) for ampicillin and amoxicillin against
anaerobes have been reported to be identical.7 Amoxicillin
breakpoints have been considered to be equivalent to ampicillin
breakpoints.
Enriched Brucella blood agar plates without antibacterial
agents were used for growth and purity controls for the
strains (by anaerobic incubation) and aerobic/facultative
contaminant control (by aerobic incubation). The control
strains used were two laboratory anaerobic isolates
(Prevotella intermedia and Clostridium perfringens) with
known antibiotic MICs.
STATISTICAL ANALYSIS
Differences between groups were compared by using Chi-
square test with or without Yates’ correction factor. Yates’
correction factor for continuity was included in the calculation
of Chi-square values for 2 × 2 tables when the expected
frequency was <10 in one or more cells.
RESULTS
Anaerobic bacteria (174 strains within 18 genera) were found
in 88 (74.6%) of the 118 specimens. Anaerobes only were
present in 23 (19.5%) specimens, aerobic/facultative bacteria
only in 20 (16.9%) and mixed aerobic/anaerobic flora in 65
(55.1%). No growth was detected in 10 (8.5%) specimens.
Two or more anaerobes per specimen were found in 56
(63.6%) of the specimens yielding anaerobes. The incidence
of isolation of anaerobes from patients with identified
odontogenic sources of infection was 82.2% (60 of 73 cases)
and that in patients with other sources of infection was 71.4%
(15 of 21, p  0.20).
The predominant anaerobic bacteria were Prevotella (49
strains), Fusobacterium species (22), Actinomyces species
(21), anaerobic cocci (20) and Eubacterium species (18)
(Table1). Microaerophilic streptococci were found in 28
(23.7%) of the specimens and, in most cases (89.3%), were
associated with anaerobes.
Amoxicillin resistance in Gram-negative anaerobes from
patients treated with -lactams was slightly more common
(34%, 17 of 50) than in those from other patients (14.3%,
4 of 28; p  0.10) (Table 2). Low rates of nonsusceptibility to
both amoxicillin and metronidazole were detected in Gram-
negative anaerobes (1.3%, 1 of 78 strains). However, it is
important to stress that -lactamase testing of anaerobic
organisms is useful and recommended,7 because all
-lactamase-positive Gram-negative anaerobes should be
considered as resistant, independently of their ampicillin MIC
values. In addition, for Gram-positive anaerobes, there is no
ampicillin breakpoint. The susceptibility breakpoint for Gram-
positive anaerobes should be higher than that for Gram-negative
anaerobes.8 Therefore, although in the present study three
Gram-positive anaerobic strains exhibited amoxicillin MICs
of >1µg ml–1, they should not be considered as amoxicillin-
resistant strains.
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Prevotella intermedia, Fusobacterium nucleatum,
Prevotella melaninogenica and the Bacteroides fragilis
group were the most common Gram-negative anaerobic
species, accounting for 9.2, 9.2, 7.5 and 4% respectively, of
all anaerobic strains. Bacteroides fragilis group strains
included Bacteroides fragilis (two strains), Bacteroides
vulgatus (one), Bacteroides distasonis (one) and three other
strains. Gram-positive anaerobic cocci (GPAC) were detected
in 16 (13.6%) specimens and Finegoldia magna accounted
for 37.5% of all GPAC strains. About half of the 21
Actinomyces strains belonged to Actinomyces odontolyticus.
Among the aerobic/facultative isolates from the patients of
the Peoples University Hospital of Maxillofacial Surgery in
2006 to 2011, 68% were Gram-positive cocci, 30.5% were
Gram-negative bacteria and 1.5% were Candida species.
DISCUSSION
Abscesses and cellulitis of the head and neck are severe
diseases. A nontreated 79-year-old man with cellulitis of the
floor of the mouth died 2 hours after admission to the hospital.
His specimen yielded Fusobacterium necrophorum,
Finegoldia magna, microaerophilic streptococci and
Bifidobacterium and Lactobacillus species. The resistance
rate to amoxicillin of Gram-negative anaerobes was 26.9%
(21 of 78 strains). Resistance rates to clindamycin and
metronidazole of Gram-negative anaerobes were 5.4% (4 of
74) and 2.5% (2 of 79) respectively, and those of Gram-positive
species were 4.5% (3 of 66) and 58.3% (42 of 72), respectively.
Only one strain was not susceptible to ampicillin/sulbactam.
In the present study, the predominant anaerobic species
were similar to those reported by Brook (2004);9 however,
isolates of Porphyromonas species were relatively rare. The
involvement of microaerophilic streptococci was considered
as, recently, members of the ‘Streptococcus milleri’ group
have been recognized as important pathogens in head and neck
abscesses.10
The detection rate of anaerobes from patients with deep-
space head and neck infections was relatively lower than that
Table 1: Anaerobic bacteria isolated from head and neck infections treated or not treated before sampling
Organism/group Total no. (%) of strains No. (%) of strains from No. (%) of strains from
nontreated patients treated patients
Gram-negative 90 (51.7) 25 (54.3) 65 (50.8)
Bacteroides fragilis group 7 (4.0) 2 (4.3) 5 (3.9)
Fusobacterium species 22 (12.6) 10 (21.7) 12 (9.4)
F. nucleatum 16 (9.2) 6 (13.0) 10 (7.8)
F. necrophorum 3 (1.7) 2 (4.3) 1 (0.8)
F. mortiferum 3 (1.7) 2 (4.3) 1 (0.8)
Prevotella spp. 49 (28.2) 10 (21.7) 39 (30.5)
P. melaninogenica 13 (7.5) 2 (4.3) 11 (8.6)
P. intermedia 16 (9.2) 5 (10.9) 11 (8.6)
P. oris 4 (2.3) 0 (0) 4 (3.1)
P. loescheii 2 (1.1) 1 (2.2) 1 (0.8)
P. disiens 2 (1.1) 0 (0) 2 (1.6)
P. denticola 2 (1.1) 0 (0) 2 (1.6)
P. corporis 1 (0.6) 0 (0) 1 (0.8)
Nonpigmented Prevotella spp. 9 (5.2) 2 (4.3) 7 (5.5)
Porphyromonas spp. 3 (1.7) 1 (2.2) 2 (1.6)
Sutterella wadsworthensis* 2 (1.1) 0 (0) 2 (1.6)
Capnocytophaga spp.* 3 (1.7) 1 (2.2) 2 (1.6)
Veillonella spp. 4 (2.3) 1 (2.2) 3 (2.3)
Gram-positive 84 (48.3) 21 (45.6) 63 (49.2)
Actinomyces spp.* 21 (12.1) 6 (13.0) 15 (11.7)
A. odontolyticus 11 (6.3) 3 (6.5) 8 (6.2)
A. israelii 2 (1.1) 1 (2.2) 1 (0.8)
Other Actinomyces spp. 8 (4.6) 2 (4.3) 6 (4.7)
Bifidobacterium spp. 3 (1.7) 1 (2.2) 2 (1.6)
Clostridium tertium 1 (0.6) 0 (0) 1 (0.8)
Eubacterium spp. 18 (10.3) 3 (6.5) 15 (11.7)
Eggerthella lenta 5 (2.9) 3 (6.5) 2 (1.6)
GPAC† 16 (9.2) 2 (4.3) 14 (10.9)
Finegoldia magna 6 (3.4) 2 (4.3) 4 (3.1)
Micromonas micros 2 (1.1) 0 (0) 2 (1.6)
Peptostreptococcus anaerobius 3 (1.7) 0 (0) 3 (2.3)
Other and nonidentified GPAC 5 (2.9) 0 (0) 5 (3.9)
Lactobacillus spp.* 13 (7.5) 5 (10.9) 8 (6.2)
Propionibacterium spp.* 7 (4.0) 1 (2.2) 6 (4.7)
All anaerobic strains 174 46 128
*Microaerophilic species, †GPAC: Gram-positive anaerobic cocci.
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Table 2: Resistance patterns of anaerobic isolates from two patients’ groups (not treated and empirically treated) with abscess or
cellulitis of the head and neck
Organism (no. of strains) Agent Not treated Empirically treated
No. of % R % I No. of % R % I
strains strains
Bacteroides fragilis group(7) Amoxicillin 2 2 0 5 5 0 7 7
Metronidazole 2 0 0 5 0 0 7 0
Clindamycin 2 0 2 4 1 1 6 1
Ampicillin/sulbactam 2 0 0 4 0 0 6 0
Prevotella and Porphyromonas Amoxicillin 10 1 0 39 10 1 49 11
spp.(49) Metronidazole 10 0 0 39 0 0 49 0
Clindamycin 10 0 0 37 2 3 47 2
Ampicillin/sulbactam 10 0 1 33 0 0 43 0
Fusobacterium species(15) Amoxicillin 8 0 1 7 1 2 15 1
Metronidazole 8 0 0 7 0 0 15 0
Clindamycin 8 1 0 6 0 0 14 1
Ampicillin/sulbactam 8 0 0 7 0 0 15 0
Other Gram-negative anaerobes(8) Amoxicillin 2 1 0 5 1 0 7 2
Metronidazole 2 0 1 6 2 0 8 2
Clindamycin 2 0 0 5 0 0 7 0
Ampicillin/sulbactam 1 0 0 4 0 0 5 0
Gram-positive anaerobic cocci(14) Metronidazole 2 0 0 12 1 0 14 1
Clindamycin 2 0 1 10 0 0 12 0
Ampicillin/sulbactam 2 0 0 12 0 0 14 0
Clostridium tertium(1) Metronidazole 0 0 0 1 1 0 1 1
Clindamycin 0 0 0 1 0 0 1 0
Ampicillin/sulbactam 0 0 0 1 0 0 1 0
Gram-positive nonspore-forming Metronidazole 15 11 0 42 29 0 57 40
rods(57) Clindamycin 15 1 0 38 2 2 53 3
Ampicillin/sulbactam 15 0 0 41 0 0 56 0
% I: Percentage intermediately susceptible; % R: Percentage resistant
(82-100%) observed by Jousimies-Somer et al (2002),2 but
was higher than that (21-59.3%, according to the sources of
infection) reported by Huang et al (2006).11 Detection rates
of anaerobes were similar in children (75%, 3 of 4 cases),
adults (74.8%, 77 of 103) and the elderly (72.7%, 8 of 11;
p  0.20). The rate of isolation of anaerobes from empirically
treated patients was slightly lower (72.4%, 63 of 87) than that
from nontreated patients (80.6%, 25 of 31; p  0.20).
The rate of isolation of Fusobacterium species from non-
treated patients (32.2%, 10 of 31) was higher than that from
treated patients (13.8%, 12 of 87, p  0.05), whereas no
significant difference (p  0.10) was observed between groups
for Prevotella species. The start of empirical treatment appears
to influence the frequency or rate of isolation of Fusobacterium
species.
Species of the Bacteroides fragilis group have been
detected in single cases of head and neck (0.9%) and
pleuropulmonary (0.3%) infections (Jousimies-Somer et al
2002).2 In the present study, Bacteroides fragilis group species
were isolated more often (in 5.9%, 7 of 118 specimens) and
accounted for 4% of all anaerobic strains. Similarly, these
organisms accounted for 5.7% of anaerobic isolates from the
respiratory tract, according to Piérard et al (2003).12
Clostridia are unusual isolates in head and neck infections
(Jousimies-Somer et al 2002).2 In the present study, a
metronidazole-resistant Clostridium tertium strain was
found in association with Prevotella corporis and
Propionibacterium acnes in a treated patient with cellulitis
of the floor of the mouth. Metronidazole resistance has been
reported in Clostridium tertium and some other clostridial
species.13-15
For the Gram-negative anaerobes, the rates of non-
susceptibility to amoxicillin (32%, 25 of 78 strains) and
clindamycin (13.5%, 10 of 74) were lower than those to
penicillin (81.8%) and clindamycin (31.1%) in Greece
(Papaparaskevas et al 2005).3 Penicillin resistance has been
found in 83% of Prevotella isolates (Aldridge et al 2001),1 as
well as in 32 to 35% of those in odontogenic infections
(Kuriyama et al 2001).5
 In the present study, amoxicillin resistance was present
in 10 (21.7%) of 46 Prevotella strains. One (6.7%) of 15
Fusobacterium strains was amoxicillin resistant and three
(20%) strains were intermediately susceptible to the agent.
-lactam-resistant Porphyromonas species have been reported
by Aldridge et al (2001),1 but have not been detected in other
studies (Kuriyama et al 2001, Bahar et al 2005).5,16 In the
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present work, one of three Porphyromonas strains was
amoxicillin resistant.
The susceptibility rate of Prevotella species to clindamycin
(88.6%, 39 of 44 strains) was similar to that (90%) reported
in odontogenic abscesses by Sobottka et al (2002).4 However,
clindamycin resistance in Prevotella strains (4.5%, 2 of 44
strains) was lower than that (22.2%) observed by Wexler et al
(2002).17 Clindamycin resistance rates were relatively low in
both Gram-negative (5.4%) and Gram-positive (4.5%)
anaerobes. Ampicillin/sulbactam was the most active agent
evaluated. Orofacial anaerobes are usually susceptible to
ampicillin/sulbactam and amoxicillin/clavulanate (Kuriyama
et al, 2000),5 although recent studies have reported a decreased
activity of these agents against 5 to 8% of Bacteroides fragilis
group strains and some Peptostreptococcus anaerobius
isolates (Aldridge et al 2001; Kato et al, 2000; Koeth et al,
2004).1,18,19
Intermediate susceptibility to amoxicillin/clavulanate has
been detected in single Prevotella strains by Wexler et al
(2002).17 In the present study, one Prevotella oralis strain
was both amoxicillin resistant and intermediately susceptible
to ampicillin/sulbactam. No resistance to ampicillin/sulbactam
was observed in Bacteroides fragilis group strains, although
one ampicillin/sulbactam-resistant Bacteroides fragilis group
isolate was detected in a patient (not involved in the study)
with malignancy and maxillofacial wound infection in 2009.
CONCLUSION
The wide diversity and susceptibility patterns of anaerobic
species motivate the use, wherever possible, of anaerobic
microbiology in maxillofacial surgery departments.
The limitation of the study was that when prior antibiotic
coverage was given to the patient, isolation of microbial
species was negative. The start of empirical treatment could
influence the frequency or rate of isolation of Fusobacterium
species. Involvement of the Bacteroides fragilis group in some
severe head and neck infections should be considered.
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